Advertisement
Screener

ILLUMINA, INC. (ILMN) Payments to Acquire Debt Securities, Available-for-sale

2.1 / 5 stars · 51/120 Roast Me

ILLUMINA, INC. Payments to Acquire Debt Securities, Available-for-sale

ILLUMINA, INC. (ILMN) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-16.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2024-02-16

  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2023-01-01 was $0.00.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-10-02 was $0.00.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-07-03 was $0.00.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-04-03 was $0.00, a 100.00% decline year-over-year.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $0.00.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $77.00M, a 95.73% decline from fiscal 2021.
  • ILLUMINA, INC. payments to acquire debt securities, available-for-sale for fiscal 2021 was $1.80B, a 78.42% increase from fiscal 2019.
Period endPayments to Acquire Debt Securities, Available-for-sale 3 monthPayments to Acquire Debt Securities, Available-for-sale 6 monthPayments to Acquire Debt Securities, Available-for-sale 9 monthPayments to Acquire Debt Securities, Available-for-sale 12 month
2023-12-31$0.00
10-K · filed 2024-02-16
2023-01-01$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
$0.00
derived: sum of 2 quarters · filed 2024-02-16
$0.00
derived: sum of 3 quarters · filed 2024-02-16
$0.00
10-K · filed 2024-02-16
2022-10-02$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$0.00
derived: sum of 2 quarters · filed 2022-11-04
$0.00
10-Q · filed 2022-11-04
$0.00
derived: sum of 4 quarters · filed 2024-02-16
2022-07-03$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$0.00
10-Q · filed 2022-08-11
$0.00
derived: sum of 3 quarters · filed 2024-02-16
$0.00
derived: sum of 4 quarters · filed 2024-02-16
2022-04-03$0.00
10-Q · filed 2022-05-05
$0.00
derived: sum of 2 quarters · filed 2024-02-16
$0.00
derived: sum of 3 quarters · filed 2024-02-16
$0.00
derived: sum of 4 quarters · filed 2024-02-16
2022-01-02$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
$0.00
derived: sum of 2 quarters · filed 2024-02-16
$0.00
derived: sum of 3 quarters · filed 2024-02-16
$77.00M
10-K · filed 2024-02-16
2021-10-03$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$0.00
derived: sum of 2 quarters · filed 2022-11-04
$77.00M
10-Q · filed 2022-11-04
$1.12B
derived: sum of 4 quarters · filed 2023-02-17
2021-07-04$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$77.00M
10-Q · filed 2022-08-11
$1.12B
derived: sum of 3 quarters · filed 2023-02-17
$1.33B
derived: sum of 4 quarters · filed 2023-02-17
2021-04-04$77.00M
10-Q · filed 2022-05-05
$1.12B
derived: sum of 2 quarters · filed 2023-02-17
$1.33B
derived: sum of 3 quarters · filed 2023-02-17
$1.62B
derived: sum of 4 quarters · filed 2023-02-17
2021-01-03$1.04B
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17
$1.25B
derived: sum of 2 quarters · filed 2023-02-17
$1.55B
derived: sum of 3 quarters · filed 2023-02-17
$1.80B
10-K · filed 2023-02-17
2020-09-27$210.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$501.00M
derived: sum of 2 quarters · filed 2021-11-05
$757.00M
10-Q · filed 2021-11-05
$1.01B
derived: sum of 4 quarters · filed 2022-02-18
2020-06-28$291.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$547.00M
10-Q · filed 2021-08-06
$797.00M
derived: sum of 3 quarters · filed 2022-02-18
$1.16B
derived: sum of 4 quarters · filed 2022-02-18
2020-03-29$256.00M
10-Q · filed 2021-04-28
$506.00M
derived: sum of 2 quarters · filed 2022-02-18
$873.00M
derived: sum of 3 quarters · filed 2022-02-18
$1.15B
derived: sum of 4 quarters · filed 2022-02-18
2019-12-29$250.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
$617.00M
derived: sum of 2 quarters · filed 2022-02-18
$893.00M
derived: sum of 3 quarters · filed 2022-02-18
$1.01B
10-K · filed 2022-02-18
2019-09-29$367.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30
$643.00M
derived: sum of 2 quarters · filed 2020-10-30
$760.00M
10-Q · filed 2020-10-30
$1.27B
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30$276.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$393.00M
10-Q · filed 2020-08-07
$900.00M
derived: sum of 3 quarters · filed 2021-02-17
$2.12B
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31$117.00M
10-Q · filed 2020-05-01
$624.00M
derived: sum of 2 quarters · filed 2021-02-17
$1.84B
derived: sum of 3 quarters · filed 2021-02-17
$2.38B
derived: sum of 4 quarters · filed 2021-02-17
2018-12-30$507.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$1.72B
derived: sum of 2 quarters · filed 2021-02-17
$2.26B
derived: sum of 3 quarters · filed 2021-02-17
$2.86B
10-K · filed 2021-02-17
2018-09-30$1.22B
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25
$1.75B
derived: sum of 2 quarters · filed 2019-10-25
$2.35B
10-Q · filed 2019-10-25
2018-07-01$539.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$1.14B
10-Q · filed 2019-07-31
2018-04-01$598.00M
10-Q · filed 2019-04-26
2017-12-31$742.00M
10-K · filed 2020-02-11
2017-01-01$895.00M
10-K · filed 2019-02-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
WATERS CORP /DE/ (WAT)United States$42.297B224.28
AGILENT TECHNOLOGIES, INC. (A)United States$48.720B27.14
METTLER TOLEDO INTERNATIONAL INC/ (MTD)$30.436B30.62
REVVITY, INC. (RVTY)United States$16.814B53.44
Avantor, Inc. (AVTR)United States$10.501B-9.72
BRUKER CORP (BRKR)United States$9.706B-128.75
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53